Earlier this year, proposed regulations on video games tanked Chinese gaming stocks. It's a sign that tough governance is ahead — for both digital content industries and governments around the world, writes researcher Brandon Zheng.
The Office of the United States Trade Representative recently stepped back from ongoing negotiations on digital trade at the World Trade Organization, citing unsettled domestic policy, and suspended support for digital trade rules in the Indo-Pacific Economic Framework too. But if the U.S. wants to be a part of the conversation, it should reengage and help craft rules flexible enough to meet its future domestic policy needs, writes nonresident fellow Simon Lester.
At least a dozen countries, including the U.S., have suspended funding to the United Nations agency that delivers aid to Palestinian refugees. The cuts fit a long-time pattern of the politicization of refugee aid, write Nicholas R. Micinski and Kelsey Norman.
Nicholas R. Micinski, Kelsey NormanFebruary 1, 2024
Despite recent claims that “free trade is dead,” fellow Simon Lester explains that America was never close to anything resembling free trade in the first place. Instead, current U.S. trade policy, just like past policy, reflects a messy mix of free market and industrial policy views.
Decades of bad policy have heightened the risks of drug use and created barriers to treatment. And while some states are now trying to reduce the harms caused by the drug war, Texas is doubling down on ineffective policies.
The latest rivalry between China and Japan is over digital media, specifically over what countries can claim the label of “anime.” But what’s going on is much more complex than the oversimplified “China vs. Japan” narrative, writes research associate Brandon Zheng.
The rapid adoption of telemedicine is one of the few positive developments of the COVID-19 pandemic, writes fellow Katharine Neill Harris. She explains why the DEA’s recent proposal to change the rules for prescribing drugs via telemedicine would harm patients and increase demand for and exposure to unregulated and more dangerous drugs.